Creative Planning’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.3K Buy
23,624
+2,515
+12% +$5.9K ﹤0.01% 3991
2025
Q4
$57.2K Buy
21,109
+10,106
+92% +$33.2K ﹤0.01% 3792
2025
Q3
$46.5K Sell
11,003
-7,702
-41% -$33.9K ﹤0.01% 3763
2025
Q2
$93.2K Buy
+18,705
New +$81.2K ﹤0.01% 3446
2023
Q3
Sell
-12,109
Closed -$66.8K 2956
2023
Q2
$66.8K Buy
12,109
+839
+7% +$4.51K ﹤0.01% 2410
2023
Q1
$70.4K Buy
11,270
+553
+5% +$3.08K ﹤0.01% 2299
2022
Q4
$49.9K Buy
+10,717
New +$52.8K ﹤0.01% 2230
2021
Q2
Sell
-16,285
Closed -$635K 2263
2021
Q1
$635K Buy
16,285
+7,128
+78% +$321K ﹤0.01% 1275
2020
Q4
$369K Sell
9,157
-3,446
-27% -$158K ﹤0.01% 1490
2020
Q3
$701K Buy
+12,603
New +$667K ﹤0.01% 958

Other funds holding GDRX

Creative Planning's GDRX Position: Q1 2026 in Review

Creative Planning increased its GoodRx Holdings (GDRX) stake by 12% in Q1 2026, buying an estimated $5.9K and bringing the position to 23,624 shares worth $46.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3991.

Creative Planning first reported a position in GDRX in Q3 2020 and has held it in 10 quarters since. The position peaked at $701K in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Creative Planning held 23,624 shares of GoodRx Holdings worth $46.3K as of Q1 2026.
  • Creative Planning bought 2,515 GoodRx Holdings shares in Q1 2026, an estimated $5.9K.
  • GoodRx Holdings made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3991 holding.
  • Creative Planning first reported a position in GoodRx Holdings in Q3 2020 and has held it in 10 quarters since.
  • Creative Planning's GoodRx Holdings position peaked at $701K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.